Zubsolv Lawsuit
Zubsolv is an anti-opioid medication that has been associated with severe teeth injuries. Learn more below.
Zubsolv is used to treat opioid addictions; however, the drug has been reported to cause severe side effects.
What is Zubsolv?
Zubsolv is an anti-opioid medication used to treat opioid (narcotic) addiction. The drug is manufactured by Orexo US, Inc.
Zubsolv contains the active ingredient buprenorphine and naloxone and is administered via a dissolving tablet in the mouth.
Opioid Addiction
Opioid use addiction (OUD) is a serious epidemic in America today. The condition is responsible for the majority of overdose deaths in the U.S. When someone is addicted to opioids, it becomes a drug that the person cannot live without, with irresistible cravings and compulsive drug use.
Dental Injuries
Zubsolv has been associated with severe tooth decay, thought to be due to the acidity of the sublingual buprenorphine/naloxone products. Since 2012, medical literature has reported tooth decay associated with the use of medications containing buprenorphine that are administered orally. In addition, the FDA reported hundreds of adverse events related to tooth decay annually. During this period, 40% of tooth decay incidents were labeled serious.
On Jan. 12, 2022, the FDA issued a warning that dental problems have been reported with medication containing buprenorphine that is dissolved in the mouth. Such dental side effects include any of the following:
- Oral infections
- Tooth decay
- Cavities
- Tooth loss
Product Liability Lawsuit
The drug Zubsolv is alleged to have caused severe teeth injuries; however, the medication did not include any warnings relating to tooth decay, cavities, oral infections, or loss of teeth before June 2022. These side effects have occurred even if the consumer has had no dental issues in the past.